{{item.videoDuration}}
{{item.title}}
{{item.videoDuration}}
Holger Schmidt
Partner, Strategy& Germany
Holger Schmidt is an advisor to executives in the health industry for Strategy&, PwC’s strategy consulting group. He is a Partner at Strategy& Germany, based in Berlin. He is a member of the global Health practice, focuses on R&D and commercial strategy, and works with pharmaceutical, biotech, and medtech companies and providers. He also has cross-industry experience in telecommunications and consumer goods. His experience spans the E.U., U.S., and emerging markets, including Brazil, Russia, Korea, and Australia.
His areas of expertise include:
- Product and portfolio strategies along the whole product lifecycle (e.g. R&D strategies, launch strategies, LCM strategies)
- Business strategies (e.g. due diligences, growth strategies, corporate strategies)
- Organisational strategies (e.g. business process design, organizational design, change)
Holger Schmidt’s client work has included:
Product and portfolio strategies
- Brand strategy and launch program for a respiratory product
- Launch planning for a cardiovascular product
- Mature markets pricing strategy for a consumer brand
- LCM strategy for a mature cardiovascular product
- Portfolio strategy oncology
Business strategies
- Corporate strategy for a biotech startup
- Commercial due diligence of a major hospital chain
- Go to market model development for a medtech startup
- Business plan evaluation of a nuclear research facility
- Business blueprint for a patient service program
- Business concept for a healthcare focused real estate development at a major airport
- Enabling growth for a pharmaceutical contract manufacturer
- Healthcare strategy for a major testing, inspection, certification company
Organizational strategies
- Set up of a global market access organisation for a pharma company
- Development of a portfolio management process for major pharma company
- Reorganisation of a pharma country organisation after sales decline
- Set up of a global key account management for a pharma company
- Optimisation of the go-to-market strategy and reorganisation of a country organisation of a major pharmaceutical company
A licensed physician, Holger Schmidt studied medicine at RWTH Aachen and Humboldt University Berlin and participated in exchange programs with Rijksuniversiteit Masstricht, Universidad de Barcelona and Tribhuvan University Kathmandu.
{{filterContent.facetedTitle}}
{{contentList.loadingText}}
{{contentList.loadingText}}